| Colton E Ketelhut, DR | |
|
1552 Dakota Ave S, Huron, SD 57350-4022 | |
| (605) 352-9498 | |
| Not Available |
| Full Name | Colton E Ketelhut |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 1552 Dakota Ave S, Huron, South Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346924149 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 2160 (South Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Colton E Ketelhut, DR 1552 Dakota Ave S, Huron, SD 57350-4022 Ph: (605) 352-9498 | Colton E Ketelhut, DR 1552 Dakota Ave S, Huron, SD 57350-4022 Ph: (605) 352-9498 |
News Archive
Scientists are reporting two findings that could influence the way researchers screen for, treat and assess prognosis for women with locally advanced breast cancer, an aggressive form of the disease. One finding offers a critical message regarding treatment strategy, they say.
Researchers from the Laboratory of Food Color and Quality at the University of Seville have published a study in which it is shown how certain types of cold treatment that are used by the citrus fruits industry in the preparation of juices have a great impact on the color of orange juice and on the concentration and bioaccessibility of the carotenoids present in the juice.
Kolltan Pharmaceuticals, Inc., a privately held biopharmaceutical company, today announced a license and research agreement with The Children's Hospital of Philadelphia to commence a collaboration with Yaël Mossé, M.D, an internationally recognized clinician and scientist for her work studying the causes and novel therapeutic approaches for the treatment of children diagnosed with neuroblastoma.
Researchers at the University of Michigan have evidence that a single gene controls both halves of nerve cells, and their research demonstrates the need to consider that design in the development of new treatments for regeneration of nerve cells.
Adding once-daily lixisenatide to basal insulin treatment is effective at improving glycemic control in Asian patients with Type 2 diabetes, show study findings.
› Verified 9 days ago
Amanda Wonnenberg, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1552 Dakota Ave S, Huron, SD 57350 Phone: 605-352-9498 | |
Xiomara Morales, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1552 Dakota Ave S, Huron, SD 57350 Phone: 605-352-9498 | |
Ms. Raquel Nelson, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1552 Dakota Ave S, Huron, SD 57350 Phone: 605-352-9498 |